A carregar...

In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer

BACKGROUND: Troglitazone (TGZ) is a peroxisome proliferator-activated receptor gamma (PPARγ) agonist that has been investigated as a potential chemopreventive and chemotherapeutic agent. However, the antitumor efficacy and mechanisms of TGZ in pancreatic cancer have not been extensively investigated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Exp Clin Cancer Res
Main Authors: Fujita, Megumi, Hasegawa, Ai, Yamamori, Motohiro, Okamura, Noboru
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5496133/
https://ncbi.nlm.nih.gov/pubmed/28673319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-017-0557-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!